09/30/2024
11:15 PM | Clearmind Medicine (Filer)
| Form EFFECT | |
09/24/2024
3:30 PM | Clearmind Medicine (Filer)
| Form POS AM | |
09/12/2024
3:01 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2024
3:30 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/20/2024
3:15 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024
11:15 PM | Clearmind Medicine (Filer)
| Form EFFECT | |
07/23/2024
3:15 PM | Clearmind Medicine (Filer)
| Form POS AM | |
|
06/13/2024
3:01 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/13/2024
3:01 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024
3:16 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2024
3:34 PM | Clearmind Medicine (Filer)
| Form 20-F/A | |
03/27/2024
3:34 PM | Clearmind Medicine (Filer)
| Form 20-F/A | |
03/24/2024
11:15 PM | Clearmind Medicine (Filer)
| Form EFFECT | |
03/18/2024
4:18 PM | Clearmind Medicine (Filer)
| Form 20-F/A | |
02/19/2024
11:15 PM | Clearmind Medicine (Filer)
| Form EFFECT | |
02/07/2024
12:41 PM | Clearmind Medicine (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/07/2024
6:32 AM | Clearmind Medicine (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
02/06/2024
8:52 AM | Clearmind Medicine (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
02/05/2024
3:01 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/29/2024
3:30 PM | Clearmind Medicine (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
01/22/2024
6:15 AM | Clearmind Medicine (Subject)
Iroquois Capital Management, LLC (Filed by)
| Form SC 13G | |
01/21/2024
11:15 PM | Clearmind Medicine (Filer)
| Form EFFECT | |
01/18/2024
3:15 PM | Clearmind Medicine (Filer)
| Form POS AM | |
01/16/2024
8:26 AM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2024
8:28 AM | Clearmind Medicine (Filer)
| Form 424B5 | |
12/26/2023
11:15 PM | Clearmind Medicine (Filer)
| Form EFFECT | |
12/18/2023
6:23 AM | Clearmind Medicine (Subject)
Polatov Eli (Filed by)
| Form SCHEDULE 13G/A | |
12/06/2023
8:28 AM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/28/2023
3:01 PM | Clearmind Medicine (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
